X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
[ sdv.imm ] life sciences [q-bio]/immunology (1) 1
abatacept (1) 1
adalimumab (1) 1
agent (1) 1
antitumor-necrosis-factor (1) 1
care and treatment (1) 1
clinical trials (1) 1
double-blind (1) 1
immunology (1) 1
inadequate response (1) 1
inhibitor (1) 1
life sciences (1) 1
medicine, general & internal (1) 1
multicenter (1) 1
outcomes (1) 1
research (1) 1
rheumatoid arthritis (1) 1
rituximab (1) 1
tnf inhibitors (1) 1
tumor necrosis factor (1) 1
tumor necrosis factor-tnf (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JAMA, ISSN 0098-7484, 09/2016, Volume 316, Issue 11, pp. 1172 - 1180
IMPORTANCE: One-third of patients with rheumatoid arthritis show inadequate response to tumor necrosis factor α (TNF-α) inhibitors; little guidance on choosing... 
AGENT | MEDICINE, GENERAL & INTERNAL | MULTICENTER | ADALIMUMAB | ANTITUMOR-NECROSIS-FACTOR | INADEQUATE RESPONSE | RITUXIMAB | DOUBLE-BLIND | OUTCOMES | INHIBITOR | ABATACEPT | Care and treatment | Research | Tumor necrosis factor | Rheumatoid arthritis | Clinical trials | Tumor necrosis factor-TNF | TNF inhibitors
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.